Literature DB >> 26087218

[Agressive small cell carcinoma of the ovary, hypercalcemic type, surgery and oncological treatment: case report].

M Kapoun, J Bouda, J Presl, P Vlasák, R Slunečko.   

Abstract

Small cell carcinoma of the ovary (SCCOHT) is a rare tumor typically affecting young women. It is a highly malignant tumor accompanied with poor prognosis, early relapse and low survival rates. The most significant prognostic factor is stage of the disease. Due to above mentioned factors there are no guidelines for therapy of this rare tumor. We present a case of 22-years-old patient initially treated with antibiotics under diagnosis of pelvic inflammatory disease. Due to persistent mass at left adnexa, she was indicated for diagnostic laparoscopy, converted to laparotomy and left adnexectomy with frozen section revealing unspecified malignant tumor of left ovary. A conservative operation was performed and, after diagnosis of SCCOHT was established, the patient was indicated for adjuvant chemotherapy.

Entities:  

Keywords:  SCCOHT - conservative surgery - chemotherapy.

Mesh:

Year:  2015        PMID: 26087218

Source DB:  PubMed          Journal:  Ceska Gynekol        ISSN: 1210-7832


  4 in total

1.  Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A rare case after in vitro fertilization (IVF).

Authors:  Ahmed Ghazi; Aqueela Ayaz; Tahira Hamid; Mian Usman Farooq; Nikita Islam
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

2.  Ovarian Small Cell Carcinoma: A Rare Case Report and Review of Literature.

Authors:  Savita Agarwal; Pinki Pandey; Megha Ralli; Shruti Singh
Journal:  Iran J Pathol       Date:  2018

3.  Small Cell Carcinoma of the Ovary (Hypercalcemic Type): Malignant Rhabdoid Tumor.

Authors:  Peter Kascak; Michal Zamecnik; Branislav Bystricky
Journal:  Case Rep Oncol       Date:  2016-06-10

4.  Primary ovarian small cell carcinoma of hypercalcemic type in a pregnant woman: A case report.

Authors:  Min Feng; Kaixuan Yang; Lian Xu; Yan Zhang; Juan Zou
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.